• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The temperature sensitive and attenuation phenotypes conferred by mutations in the influenza PB2, PB1, and NP genes are influenced by the species of o

tetano

Editor, Senior Moderator
J Virol. 2014 Aug 13. pii: JVI.02142-14. [Epub ahead of print]
The temperature sensitive and attenuation phenotypes conferred by mutations in the influenza PB2, PB1, and NP genes are influenced by the species of origin of the PB2 gene in reassortant viruses derived from influenza A/California/07/2009 and A/WSN/33.
Broadbent AJ1, Santos CP1, Godbout RA1, Subbarao K2.
Author information
Abstract

Live attenuated influenza vaccines in the US are derived from a human virus that is temperature sensitive (ts), characterized by restricted (≥ 100-fold) replication at 39?C. The ts genetic signature (ts sig) has been mapped to 5 loci in 3 genes: PB1 (391E, 581G, and 661T), PB2 (265S) and NP (34G). However, when transferred into avian and swine influenza viruses, only partial ts and attenuation phenotypes occur. To investigate the reason for this, we introduced the ts sig into the human-origin virus A/WSN/33 (WSN), the avian-origin virus A/Vietnam/1203/04 (VN04), and the swine-origin triple reassortant 2009 pandemic H1N1 virus A/California/07/2009 (CA07), which contains gene segments from human-, avian- and swine-viruses. The VN04 ts sig and CA07 ts sig viruses replicated efficiently in MDCK cells at 39?C, but the replication of WSN ts sig was restricted ≥ 100-fold compared to 33?C. Reassortant CA07 ts sig viruses were generated with individual polymerase gene segments from WSN, and vice versa. Only ts sig viruses with a PB2 gene segment derived from WSN were restricted in replication ≥ 100-fold at 39?C. In ferrets, the CA07 ts sig virus replicated in the upper and lower respiratory tracts, but the replication of a reassortant CA07 ts sig virus with a WSN PB2 gene was severely restricted in the lungs. Taken together, these data suggest that the origin of the PB2 gene segment influences the ts phenotype in vitro and attenuation in vivo. This could have implications for the design of novel live vaccines against animal-origin influenza viruses.
IMPORTANCE:

Live attenuated influenza vaccines (LAIV) on temperature sensitive (ts) backbones derived from animal-origin influenza viruses are being sought for use in the poultry and swine industries and to protect people against animal-origin influenza. However, inserting the ts genetic signature from a licensed LAIV backbone fails to fully attenuate these viruses. Our data indicate this is associated with the presence of a PB2 gene segment derived from an avian influenza virus. We show that a reassortant 2009 pandemic H1N1 virus with the ts signature from a licensed LAIV donor virus is ts in vitro and attenuated in vivo when the PB2 gene is derived from a human-origin virus but not from an avian virus. Our study provides information that could benefit the rational design of alternative LAIV backbones against animal-origin influenza viruses.

Copyright ? 2014, American Society for Microbiology. All Rights Reserved.

PMID:
25122786
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25122786
 
Back
Top Bottom